Elevance Health Inc., operating as a leading health benefits organization, provides comprehensive solutions across medical and clinical care, digital tools, pharmacy services, and behavioral health offerings. Analyzing recent analyst recommendations reveals a continued positive sentiment, although there are indicators of growing caution among traders. Understanding these trends can offer a clearer perspective on potential market directions.
The latest analyst ratings for Elevance Health Inc. indicate a cautiously optimistic outlook with the concentration primarily on 'Buy' and 'Hold'. In July 2026, the ratings were distributed as follows:
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 12 | |
| Hold | 8 | |
| Sell | 0 | |
| Strong Sell | 0 |
Over recent months, the analyst sentiment for Elevance Health Inc. has shown nuanced changes. Tracking the overall number reveals a shift from more bullish 'Strong Buys' to a rise in 'Holds', signaling a more cautious approach from analysts.
The percentage trends in ratings underscore a gradual but noticeable shift in sentiment. While 'Buy' ratings maintain their strong position, there's a clear move towards more 'Hold' recommendations, reducing the bullish posture seen in previous periods.
Recent analyst recommendations for Elevance Health Inc. show a consistency in positive outlooks, with many analysts maintaining their previous ratings.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-07-02 | Outperform | Outperform | Bernstein |
| 2026-06-08 | Outperform | Outperform | Mizuho |
| 2026-06-08 | Overweight | Overweight | JP Morgan |
| 2026-06-04 | Buy | Buy | B of A Securities |
| 2026-06-04 | Equal Weight | Equal Weight | Morgan Stanley |
Some analysts have adjusted their ratings, reflecting a shift in perspective on Elevance Health Inc.'s performance and potential future outlook.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-05-20 | Buy | Hold | Deutsche Bank |
| 2026-04-29 | Buy | Neutral | B of A Securities |
| 2026-01-08 | Outperform | Peer Perform | Wolfe Research |
| 2025-12-19 | Hold | Buy | Deutsche Bank |
| 2025-07-21 | Hold | Buy | Argus Research |
The current analyst estimates for Elevance Health Inc. suggest a largely optimistic market perspective, with a slight movement towards more conservative ratings in recent times. This shift may indicate growing caution tied to broader market conditions or underlying company performance concerns. However, no significant increase in negative views exists, highlighting sustained confidence in the company's fundamentals.
Elevance Health Inc. continues to attract positive analyst sentiment, though there's observable caution with increasing 'Hold' ratings. The prevailing sentiment reflects a mix of trust in continued stability and potential growth tempered by macroeconomic concerns or sector-specific risks. Investors should remain aware of the evolving environment while leveraging the company's solid foundation for potential opportunities.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.